Drug intelligence / Profile preview

brimonidine tartrate + timolol maleate

Development stage
Approved
Lead developer
Allergan
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Brimonidine tartrate + timolol maleate is a fixed-dose combination ophthalmic solution used to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who require adjunctive or replacement therapy. The medication combines two active ingredients with complementary mechanisms of action. Brimonidine is an alpha-2 adrenergic receptor agonist that decreases aqueous humor production and increases uveoscleral outflow, thereby lowering IOP. Timolol is a non-selective beta-adrenergic receptor antagonist (beta blocker) that reduces aqueous humor production in the ciliary body, also resulting in decreased IOP. This combination provides additive effects for lowering eye pressure and is typically administered as one drop to the affected eye(s) twice daily[1][2][5][6][8].

Brand names
Combigan
Other names
brimonidine/timolol ophthalmic solutionbrimonidine tartrate/timolol maleate ophthalmic solutionbrimonidine and timolol eye drops
02

Targets

ADRA2A (α2A)ADRB2 (β2)ADRB1 (β1)

Beyond the preview

Go deeper on brimonidine tartrate + timolol maleate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on brimonidine tartrate + timolol maleate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call